Leptospirosis

Leptospirosis is a zoonotic bacterial disease caused by pathogenic spirochetes of the genus Leptospira. It affects a wide range of mammals, including dogs, and occasionally cats, with a global distribution. The disease is characterized by acute febrile illness, renal and hepatic dysfunction, vasculitis, and a propensity for severe complications such as acute kidney injury (AKI), hepatic failure, pulmonary hemorrhage, and coagulopathies. In veterinary medicine, leptospirosis is a major differential for acute febrile illness with renal and hepatic involvement, especially in dogs with outdoor exposure. The disease can manifest in peracute, acute, subacute, or chronic forms, with clinical signs ranging from mild fever to fatal multi-organ failure. The infection is acquired through contact with urine from infected reservoir hosts, typically rodents, or contaminated water/soil. The spirochetes penetrate mucous membranes or abraded skin, then disseminate hematogenously, leading to colonization of the renal tubules and liver, among other tissues. The clinical course is influenced by the infecting serovar, host immune status, and the presence of concurrent disease. Early recognition and aggressive therapy are critical to improve outcomes and reduce zoonotic risk.

Leptospirosis is caused by pathogenic spirochetes of the genus Leptospira, which are Gram-negative, aerobic, motile, and tightly coiled bacteria. The genus is classified into over 250 serovars based on lipopolysaccharide (LPS) antigens, with more than 30 serovars known to infect dogs. The most common serovars associated with canine disease include Canicola, Icterohaemorrhagiae, Grippotyphosa, Pomona, Bratislava, and Australis. In recent years, serovars such as Grippotyphosa and Pomona have become increasingly prevalent in North America, while Canicola and Icterohaemorrhagiae were historically more common. The bacteria are maintained in the environment by reservoir hosts, particularly wild and domestic animals, which shed the organism in urine. Rodents, especially rats, are the primary reservoir for Icterohaemorrhagiae, while dogs can serve as reservoirs for Canicola. Transmission occurs through direct contact with infected urine, or indirectly via contaminated water, soil, or fomites. The spirochetes enter the host through mucous membranes (oral, nasal, ocular) or abraded skin, and then multiply in the bloodstream during the leptospiremic phase, which lasts for about 4-12 days. The organisms then localize in the proximal renal tubules, liver, and other tissues, where they can persist for weeks to months, leading to chronic shedding. Virulence factors include LPS, outer membrane proteins, and hemolysins, which contribute to endothelial damage, vasculitis, and tissue necrosis. The bacteria are susceptible to desiccation, heat, and common disinfectants, but can survive in moist, warm environments for extended periods.

Leptospirosis has a worldwide distribution, with higher incidence in tropical and subtropical regions, as well as in temperate areas during warm, rainy seasons. In dogs, the disease is more common in males, likely due to increased roaming behavior, and in young to middle-aged dogs (1-6 years). Certain breeds, such as Labrador Retrievers, Golden Retrievers, and mixed-breed dogs, are overrepresented, possibly due to outdoor activities and hunting. However, any dog with access to outdoor environments, especially those that swim in stagnant water, roam in rural areas, or have contact with wildlife, is at risk. Urban dogs may also be exposed through contact with rat urine in parks or alleys. Cats are generally more resistant to clinical leptospirosis, but subclinical infection and seroconversion can occur, with potential shedding. The incidence of canine leptospirosis has been increasing in some regions, possibly due to changes in serovar prevalence, climate change, and increased awareness. In the United States, the disease is more common in the Midwest, Northeast, and Southeast, with peaks in late summer and early fall. Seroprevalence studies in dogs have shown rates ranging from 5% to 30% in endemic areas. The disease is also a significant zoonotic concern, with human cases often linked to occupational or recreational exposure to contaminated water. The epidemiology is influenced by the presence of reservoir hosts, environmental conditions, and vaccination practices. Vaccination against common serovars can reduce the incidence of clinical disease but does not prevent all infections, and breakthrough cases can occur with non-vaccine serovars.

The pathophysiology of leptospirosis involves a complex interplay between the spirochete, the host immune response, and the resulting systemic inflammatory cascade. After penetration through mucous membranes or abraded skin, the bacteria rapidly multiply in the bloodstream, causing a transient leptospiremia. During this phase, the organisms adhere to endothelial cells, leading to vasculitis and increased vascular permeability. The spirochetes then disseminate to various organs, with a predilection for the kidneys, liver, and lungs. In the kidneys, Leptospira invade the renal interstitium and proximal tubular epithelial cells, causing acute tubular necrosis and interstitial nephritis. The resulting acute kidney injury (AKI) is characterized by decreased glomerular filtration rate, azotemia, and electrolyte imbalances. The organisms can persist in the renal tubules for weeks to months, leading to chronic interstitial nephritis and chronic kidney disease (CKD) in some cases. In the liver, the spirochetes cause hepatocellular degeneration and necrosis, leading to elevated liver enzymes, hyperbilirubinemia, and impaired synthetic function. The hepatic injury is often less severe than renal injury but can contribute to coagulopathies and jaundice. Pulmonary involvement, particularly pulmonary hemorrhage, is a severe complication and is thought to be due to immune-mediated vasculitis and endothelial damage, leading to alveolar hemorrhage and acute respiratory distress. The systemic inflammatory response syndrome (SIRS) is triggered by the release of pro-inflammatory cytokines, such as tumor necrosis factor-alpha (TNF-α), interleukin-1 (IL-1), and interleukin-6 (IL-6), which contribute to fever, hypotension, and multi-organ dysfunction. Coagulation abnormalities, including thrombocytopenia and disseminated intravascular coagulation (DIC), can occur due to endothelial damage and platelet consumption. The host immune response, including both humoral and cell-mediated immunity, is crucial for clearing the infection, but it also contributes to tissue damage. The severity of the disease is influenced by the infecting serovar, the infectious dose, and the host's immune status. Chronic shedding of leptospires in urine can occur in recovered animals, serving as a source of infection for other animals and humans.

Several factors predispose animals to leptospirosis, including intrinsic and extrinsic elements. Intrinsic factors include age, sex, and breed. Young to middle-aged dogs (1-6 years) are more commonly affected, possibly due to increased outdoor activity and risk-taking behavior. Males are overrepresented, likely due to roaming and fighting. Certain breeds, such as Labrador Retrievers, Golden Retrievers, and mixed-breed dogs, are more frequently diagnosed, possibly due to their use as hunting or working dogs, which increases exposure to contaminated environments. Immunosuppression, whether due to concurrent disease, stress, or medication, can increase susceptibility to infection and severity of disease. Extrinsic factors include environmental and management practices. Dogs with access to stagnant water, such as ponds, puddles, or flooded areas, are at higher risk. Rural and suburban dogs that roam freely or have contact with wildlife, particularly rodents, are more likely to be exposed. Hunting dogs and working dogs are at increased risk due to their frequent exposure to natural habitats. Overcrowding, poor sanitation, and lack of vaccination are also significant risk factors. Unvaccinated dogs or those with incomplete vaccination histories are more susceptible. Climate plays a role, with higher incidence during warm, rainy seasons and in tropical or subtropical regions. Flooding can lead to outbreaks by spreading contaminated water. Additionally, the presence of reservoir hosts, such as rats, raccoons, and skunks, in the environment increases the risk of exposure. In cats, clinical leptospirosis is rare, but subclinical infection can occur, and risk factors include outdoor access and hunting behavior.

Clinical signs of leptospirosis in dogs can vary widely, ranging from subclinical infection to peracute fatal disease. The incubation period is typically 5-14 days. The disease can be classified into peracute, acute, subacute, and chronic forms. Peracute leptospirosis is characterized by sudden onset of fever, depression, weakness, and shock, often leading to death within hours. Acute leptospirosis presents with fever (103-105°F), lethargy, anorexia, vomiting, diarrhea, and polydipsia/polyuria. As the disease progresses, signs of renal and hepatic failure become apparent, including icterus, oliguria or anuria, and abdominal pain. Subacute leptospirosis is more common and presents with similar but less severe signs, including fever, vomiting, dehydration, and muscle tenderness. Chronic leptospirosis may manifest as chronic kidney disease with polyuria, polydipsia, and weight loss, or as chronic hepatitis with icterus and ascites. Physical examination findings may include dehydration, injected mucous membranes, icterus, renomegaly or pain on renal palpation, hepatomegaly, and evidence of bleeding (petechiae, ecchymoses, melena). Pulmonary involvement can lead to cough, tachypnea, dyspnea, and hemoptysis, which are signs of pulmonary hemorrhage. Neurological signs, such as seizures or ataxia, are rare but can occur due to vasculitis or hepatic encephalopathy. In cats, clinical signs are often mild or absent, but if present, they may include fever, lethargy, vomiting, and renal or hepatic dysfunction. It is important to note that clinical signs can be nonspecific, and leptospirosis should be considered in any dog with acute febrile illness, especially with renal and hepatic involvement.

The differential diagnoses for leptospirosis include a wide range of infectious, toxic, and metabolic diseases. Key differentials include: 1) Canine distemper virus (CDV) infection, which can cause fever, respiratory signs, and neurological signs, but typically lacks renal and hepatic involvement; 2) Infectious canine hepatitis (ICH) caused by canine adenovirus-1, which presents with fever, vomiting, and hepatic dysfunction, but is less common due to vaccination; 3) Acute renal failure from other causes, such as ethylene glycol toxicity, NSAID toxicity, or ureteral obstruction, which can be differentiated by history, imaging, and specific laboratory tests; 4) Hepatic failure from other causes, such as toxic hepatopathy (e.g., xylitol, aflatoxin) or chronic hepatitis, which may present with icterus and elevated liver enzymes; 5) Bacterial sepsis or pyelonephritis, which can cause fever, vomiting, and renal dysfunction, but may have a different clinical course and response to antibiotics; 6) Pancreatitis, which can cause vomiting, abdominal pain, and elevated pancreatic enzymes, but typically lacks renal and hepatic involvement; 7) Hemorrhagic gastroenteritis (HGE), which presents with acute vomiting and bloody diarrhea, but usually without fever or organ failure; 8) Immune-mediated hemolytic anemia (IMHA), which can cause icterus and anemia, but is differentiated by a positive Coombs test and spherocytosis; 9) Babesiosis or ehrlichiosis, which are tick-borne diseases that can cause fever, anemia, and thrombocytopenia, but have different geographic distributions and diagnostic tests; 10) Hepatic lipidosis in cats, which can cause icterus and hepatic dysfunction, but is associated with anorexia and fatty liver infiltration. Definitive diagnosis of leptospirosis requires specific serological or molecular testing, such as the microscopic agglutination test (MAT) or PCR.

The diagnostic algorithm for leptospirosis begins with a thorough history and physical examination, with emphasis on exposure risk (outdoor access, stagnant water, wildlife contact) and clinical signs (fever, vomiting, renal/hepatic signs). Initial laboratory tests should include a complete blood count (CBC), serum biochemistry profile, and urinalysis. Common findings include leukocytosis or leukopenia, thrombocytopenia, elevated liver enzymes (ALT, AST, ALP), elevated bilirubin, azotemia (elevated BUN and creatinine), hyperphosphatemia, and electrolyte imbalances (hyponatremia, hypokalemia). Urinalysis may reveal proteinuria, glucosuria, bilirubinuria, and active sediment (hematuria, pyuria, casts). If leptospirosis is suspected, specific diagnostic tests should be performed. The microscopic agglutination test (MAT) is the serological gold standard, but it requires paired samples (acute and convalescent) to confirm a four-fold rise in titer. A single titer of ≥1:800 in a dog with compatible clinical signs is highly suggestive, but a titer of ≥1:3200 is considered diagnostic. However, MAT can be negative early in the disease, and false positives can occur due to vaccination. PCR testing on blood or urine is highly sensitive and specific, and can detect leptospiral DNA early in the disease. Blood PCR is most useful during the leptospiremic phase (first 7-10 days), while urine PCR can be positive from the second week onward and may remain positive for weeks. Other diagnostic tests include culture, which is difficult and slow, and immunohistochemistry on tissue biopsies. Imaging, such as thoracic radiography, may reveal pulmonary hemorrhage or interstitial infiltrates. Abdominal ultrasound may show renomegaly, increased renal cortical echogenicity, and hepatomegaly. In cases of acute kidney injury, renal biopsy may be considered, but is often not necessary if serology or PCR is positive. A diagnostic algorithm should prioritize early PCR testing on blood and urine, along with MAT on acute serum, and repeat MAT in 2-4 weeks if initial titers are low. Treatment should be initiated immediately if leptospirosis is suspected, even before confirmatory tests are available, due to the potential for severe disease and zoonotic risk.

Laboratory findings in leptospirosis are variable but often reflect renal and hepatic dysfunction. On complete blood count (CBC), common abnormalities include leukocytosis (neutrophilia with left shift) or leukopenia, thrombocytopenia (due to increased consumption or immune-mediated destruction), and mild to moderate anemia (non-regenerative initially, later regenerative). Serum biochemistry profile typically shows elevated liver enzymes: alanine aminotransferase (ALT) and aspartate aminotransferase (AST) are often moderately elevated, while alkaline phosphatase (ALP) may be elevated due to cholestasis. Hyperbilirubinemia is common, especially in icteric animals. Renal parameters are frequently elevated: blood urea nitrogen (BUN) and creatinine are increased in acute kidney injury, and hyperphosphatemia is common. Electrolyte disturbances include hyponatremia, hypokalemia, and sometimes hyperkalemia in oliguric/anuric renal failure. Metabolic acidosis may be present due to renal dysfunction and lactic acidosis. Urinalysis often reveals low urine specific gravity (isosthenuria), proteinuria, glucosuria, bilirubinuria, and active sediment with hematuria, pyuria, and granular casts. Urine protein-to-creatinine ratio (UPC) may be elevated. Blood gas analysis may show metabolic acidosis with compensatory respiratory alkalosis. Specific biomarkers: C-reactive protein (CRP) is often elevated as an acute-phase protein. SDMA (symmetric dimethylarginine) may be elevated early in renal dysfunction. Cardiac troponin I may be elevated if myocarditis is present. Serological testing: The microscopic agglutination test (MAT) is the standard serological test, with a four-fold rise in titer between acute and convalescent samples (2-4 weeks apart) being diagnostic. A single titer ≥1:800 in a symptomatic dog is highly suggestive, but vaccination can cause false positives. PCR testing on blood (during the first week) and urine (from the second week onward) is highly sensitive and specific. Culture is possible but requires special media and is slow. In cases of pulmonary hemorrhage, bronchial lavage may reveal hemosiderin-laden macrophages. Histopathology of kidney or liver biopsies can show characteristic lesions, but is rarely needed for diagnosis.

Imaging findings in leptospirosis are nonspecific but can support the diagnosis and assess complications. Thoracic radiography may reveal interstitial to alveolar patterns, especially in cases of pulmonary hemorrhage, which can appear as diffuse alveolar infiltrates or focal opacities. Pleural effusion may be present in severe cases. Abdominal radiography may show renomegaly or hepatomegaly, but is often unremarkable. Abdominal ultrasonography is more useful: the kidneys may appear enlarged with increased cortical echogenicity, loss of corticomedullary distinction, and perirenal fluid. The liver may be enlarged with increased echogenicity. In cases of acute kidney injury, Doppler ultrasound may show increased resistive index in the renal arteries. Computed tomography (CT) is rarely needed but can provide detailed assessment of pulmonary and renal changes. Magnetic resonance imaging (MRI) is not commonly used but may be indicated if neurological signs are present. Endoscopy is not typically used for diagnosis, but bronchoscopy with bronchoalveolar lavage may be performed in cases of pulmonary hemorrhage to rule out other causes. Echocardiography may be indicated if cardiac involvement is suspected, but is not a primary diagnostic tool. Imaging is primarily used to rule out other conditions and to monitor complications such as pulmonary hemorrhage or renal changes.

Cytological and histopathological findings in leptospirosis are characteristic but not pathognomonic. Fine needle aspirates (FNA) of the kidney or liver may show inflammatory cells, but are rarely performed due to the risk of hemorrhage. Fluid analysis of abdominal or thoracic effusions may reveal a modified transudate or exudate with mixed inflammatory cells. Histopathology of the kidney typically shows acute interstitial nephritis with infiltration of lymphocytes, plasma cells, and neutrophils, along with tubular necrosis and degeneration. The tubules may contain proteinaceous casts and red blood cells. In chronic cases, interstitial fibrosis and tubular atrophy are seen. The liver shows hepatocellular degeneration and necrosis, with Kupffer cell hyperplasia and bile stasis. In cases of pulmonary hemorrhage, histopathology reveals alveolar hemorrhage and edema, with evidence of vasculitis. Special stains, such as Warthin-Starry silver stain or immunohistochemistry, can be used to identify leptospires in tissues, particularly in the renal tubules and liver. Immunohistochemistry is more sensitive and specific than silver stains. In chronic carriers, leptospires may be seen in the proximal renal tubules. Histopathology is not commonly used for antemortem diagnosis, but may be performed postmortem to confirm the disease. Cytology of urine sediment may occasionally show leptospires with dark-field microscopy, but this is unreliable and not recommended.

Treatment of leptospirosis involves a multi-modal approach, including antimicrobial therapy, supportive care, and management of complications. The primary goals are to eliminate the infection, manage acute kidney injury (AKI) and hepatic dysfunction, and prevent zoonotic transmission. Antimicrobial therapy should be initiated as soon as leptospirosis is suspected, even before confirmatory tests. The drug of choice for the acute phase is doxycycline, at a dose of 5 mg/kg PO q12h for 14 days. Doxycycline is effective in eliminating the leptospiremic phase and preventing the renal carrier state. Alternatively, penicillin derivatives such as ampicillin (20 mg/kg IV q8h) or amoxicillin (20 mg/kg PO q12h) can be used initially, but they do not eliminate the carrier state, so a course of doxycycline is recommended after initial therapy. For animals that cannot tolerate oral medications, intravenous ampicillin or amoxicillin can be used until oral doxycycline can be administered. Supportive care is crucial, especially for AKI. Intravenous fluid therapy with isotonic crystalloids (e.g., lactated Ringer's solution) is indicated to correct dehydration and maintain renal perfusion. In oliguric or anuric AKI, fluid therapy must be carefully monitored to avoid fluid overload. Diuretics such as furosemide (1-2 mg/kg IV q8h) may be used to promote urine output, but should be used cautiously. In severe AKI, renal replacement therapy (hemodialysis or peritoneal dialysis) may be necessary. Management of hepatic dysfunction includes hepatoprotectants such as S-adenosylmethionine (SAMe) and ursodeoxycholic acid, and vitamin K1 (0.5-1.5 mg/kg SC q12h) if coagulopathy is present. Antiemetics such as maropitant (1 mg/kg SC q24h) or ondansetron (0.5-1 mg/kg IV q12h) are indicated for vomiting. Gastrointestinal protectants such as sucralfate (0.5-1 g PO q8h) may be used. Nutritional support is important; if the animal is anorexic, a feeding tube may be placed. In cases of pulmonary hemorrhage, oxygen supplementation and mechanical ventilation may be required. Blood transfusions may be necessary for severe anemia or coagulopathy. The prognosis depends on the severity of organ dysfunction and the timeliness of treatment. Early and aggressive therapy can lead to full recovery, but severe AKI or pulmonary hemorrhage carries a guarded prognosis.

The prognosis for leptospirosis in dogs is variable and depends on several factors, including the severity of clinical signs, the presence of multi-organ involvement, and the timeliness of treatment. With early and aggressive therapy, the survival rate is generally good, with reported survival rates of 70-90% in dogs with acute leptospirosis. However, the prognosis is guarded to poor in cases of peracute disease, severe pulmonary hemorrhage, or advanced acute kidney injury requiring dialysis. Negative prognostic indicators include severe azotemia (creatinine >5 mg/dL), oliguria or anuria, hyperkalemia, marked thrombocytopenia, and the presence of pulmonary hemorrhage. Dogs that survive the acute phase may develop chronic kidney disease (CKD) as a sequela, requiring long-term management. The renal carrier state can persist for weeks to months, and shedding of leptospires in urine can occur, posing a zoonotic risk. With appropriate antimicrobial therapy, the carrier state is usually eliminated, but repeat urine PCR may be recommended to confirm clearance. The prognosis for cats is generally good, as clinical disease is rare and often mild. Long-term prognosis is influenced by the degree of renal recovery; some dogs may have persistent renal dysfunction, while others may regain normal renal function. Regular monitoring of renal parameters is recommended in the months following recovery.

Follow-up care for leptospirosis is essential to monitor recovery, manage complications, and prevent zoonotic transmission. After initial treatment, re-evaluation should be scheduled at 1-2 weeks, 4 weeks, and 8 weeks post-diagnosis. At each visit, a physical examination, serum biochemistry profile, and urinalysis should be performed to assess renal and hepatic function. Blood pressure measurement is recommended to detect hypertension, which can occur secondary to renal disease. Urine protein-to-creatinine ratio (UPC) should be monitored if proteinuria is present. Repeat urine PCR is recommended at 4-6 weeks after completion of antimicrobial therapy to confirm clearance of the renal carrier state. If PCR remains positive, a second course of doxycycline may be considered. Serological testing (MAT) may be repeated to document a four-fold rise in titer, but is not necessary for clinical management. Long-term monitoring for chronic kidney disease (CKD) is important, especially in dogs that had significant azotemia. This may include regular measurement of SDMA, creatinine, and UPC, as well as blood pressure monitoring. Dietary management with a renal support diet may be recommended if CKD develops. Owners should be educated about the zoonotic risk and advised to practice good hygiene, including wearing gloves when handling urine, and to prevent the dog from urinating in areas where children or other animals may be exposed. Vaccination against leptospirosis should be considered for dogs at risk, with annual boosters. The follow-up schedule should be individualized based on the severity of the disease and the presence of complications.

Clinical pearls: 1) Leptospirosis should be a top differential in any dog presenting with acute fever, vomiting, and azotemia, especially if there is a history of outdoor exposure. 2) Early initiation of doxycycline is crucial, even before confirmatory tests, as it can reduce the severity and duration of disease. 3) Doxycycline is the drug of choice for eliminating the renal carrier state; penicillin derivatives do not clear the carrier state. 4) Pulmonary hemorrhage is a severe complication and can occur suddenly; thoracic radiographs should be obtained in any dog with respiratory signs. 5) Urine PCR is more sensitive than blood PCR after the first week of infection, and can be used to confirm the diagnosis and monitor clearance. 6) Vaccination does not prevent all serovars, so a history of vaccination does not rule out leptospirosis. 7) Leptospirosis is a zoonotic disease; use barrier precautions when handling urine and blood. Pitfalls: 1) Relying solely on a single MAT titer can be misleading; a four-fold rise in paired titers is needed for definitive diagnosis. 2) MAT can be negative early in the disease; PCR is more sensitive in the first week. 3) Overhydration in oliguric AKI can lead to pulmonary edema; monitor urine output and body weight closely. 4) Using penicillin alone may not eliminate the carrier state, leading to chronic shedding. 5) Failing to consider leptospirosis in cats, as they can be subclinically infected and shed the organism. 6) Not providing adequate supportive care, such as antiemetics and nutritional support, can worsen the prognosis. 7) Discontinuing antimicrobial therapy too early can lead to relapse or carrier state.

Based on Plumb's Veterinary Drug Handbook, the following drug protocols are recommended for leptospirosis: 1) Doxycycline: 5 mg/kg PO q12h for 14 days. This is the drug of choice for eliminating the leptospiremic phase and the renal carrier state. It should be given with food to reduce gastrointestinal upset. In animals with severe vomiting, intravenous doxycycline (2.5-5 mg/kg IV q12h) can be used, but it should be administered slowly to avoid phlebitis. 2) Ampicillin: 20 mg/kg IV q8h for 5-7 days, as an alternative initial therapy, especially in animals that cannot tolerate oral medications. It is effective against leptospiremia but does not eliminate the carrier state, so a course of doxycycline should follow. 3) Amoxicillin: 20 mg/kg PO q12h for 5-7 days, as an alternative to ampicillin. 4) For supportive care: Intravenous fluids: isotonic crystalloids (e.g., lactated Ringer's solution) at a rate to correct dehydration and maintain perfusion, typically 60-100 ml/kg/day, adjusted based on urine output and hydration status. 5) Furosemide: 1-2 mg/kg IV q8h, if oliguric or anuric AKI is present, to promote urine output. 6) Maropitant: 1 mg/kg SC q24h for vomiting. 7) Ondansetron: 0.5-1 mg/kg IV q12h for vomiting. 8) S-adenosylmethionine (SAMe): 20 mg/kg PO q24h for hepatic support. 9) Ursodeoxycholic acid: 10-15 mg/kg PO q24h for cholestasis. 10) Vitamin K1: 0.5-1.5 mg/kg SC q12h for 3-5 days if coagulopathy is present. 11) Sucralfate: 0.5-1 g PO q8h for gastrointestinal protection. 12) In cases of severe AKI, renal replacement therapy (hemodialysis or peritoneal dialysis) may be indicated. Dosages should be adjusted in animals with renal or hepatic impairment. Doxycycline should be used with caution in animals with hepatic disease, and dose adjustments may be necessary. Ampicillin and amoxicillin are generally safe in renal impairment but may require dose adjustments. Contraindications: Doxycycline is contraindicated in animals with known hypersensitivity to tetracyclines. Furosemide should be used with caution in animals with dehydration or electrolyte imbalances. Drug interactions: Doxycycline may interact with antacids, iron supplements, and calcium-containing products, reducing its absorption. Ampicillin may interact with bacteriostatic antibiotics, reducing its efficacy. Vitamin K1 may interact with warfarin. It is important to monitor renal and hepatic parameters during treatment.

Evidence-based literature on leptospirosis in dogs includes several key studies and consensus guidelines. The ACVIM consensus statement on leptospirosis (2019) provides evidence-based recommendations for diagnosis, treatment, and prevention. Key points include: 1) The microscopic agglutination test (MAT) remains the serological gold standard, but PCR on blood and urine is recommended for early diagnosis. 2) Doxycycline is the recommended antimicrobial for both treatment and elimination of the carrier state. 3) Aggressive fluid therapy is essential for managing AKI, but careful monitoring is required to avoid fluid overload. 4) Vaccination with quadrivalent vaccines (including serovars Canicola, Icterohaemorrhagiae, Grippotyphosa, and Pomona) is recommended for dogs at risk. A study by Goldstein et al. (2006) evaluated the clinical and laboratory features of 76 dogs with leptospirosis and found that the most common clinical signs were lethargy, vomiting, and anorexia, and that azotemia and elevated liver enzymes were common. Another study by Sykes et al. (2011) compared PCR and MAT for diagnosis and found that PCR was more sensitive early in the disease. A study by Kohn et al. (2010) reported that dogs with pulmonary hemorrhage had a higher mortality rate. A meta-analysis by Schuller et al. (2015) assessed the efficacy of different antimicrobial protocols and concluded that doxycycline is superior to penicillin for eliminating the carrier state. The ISCAID guidelines on antimicrobial use in canine urinary tract infections also address leptospirosis, recommending doxycycline as the first-line treatment. Overall, the evidence supports early and aggressive treatment with doxycycline, supportive care, and vaccination for prevention.